Industries

Cell Therapy

Cell therapy engineers living cells—predominantly T cells and NK cells—as therapeutic agents, with CAR-T programs for hematological cancers leading commercial adoption. The field recruits immunology and gene-editing PhDs and relies on university labs for novel receptor discovery, ipsc differentiation, and manufacturing process research.

Details

Companies

Bristol-Myers Squibb JunoKite Pharma GileadNovartis PharmaceuticalsFate TherapeuticsAtara BiotherapeuticsPrecision BioSciencesCaribou BiosciencesPoseida Therapeutics2seventy bioCellular Biomedicine Group

Market Size

$14B

Target Researchers

Immunologists, cell biologists, and molecular biologists with expertise in CAR-T engineering, allogeneic cell manufacturing, T-cell receptor therapy, stem cell differentiation, and GMP cell production

Use Cases

CAR construct licensingiPSC differentiation protocol partnershipsGene editing tool procurementCell manufacturing scale-up consultingViral vector supply contractsT-cell engineering co-development